期刊
ISRAEL JOURNAL OF CHEMISTRY
卷 56, 期 6-7, 页码 431-444出版社
WILEY-V C H VERLAG GMBH
DOI: 10.1002/ijch.201500089
关键词
cycloaddition; cyclopropanes; fragmentation; heterocycles; rearrangement
资金
- A. P. Sloan Foundation
- Abbott
- American Cancer Society [JFRA-523]
- Amgen
- Astellas Pharma
- AstraZeneca
- Bayer Corporation
- Boehringer Ingelheim
- Bristol-Myers Squibb
- Caltech
- Camille and Henry Dreyfus Foundation
- Eli Lilly
- Elsa U. Pardee Foundation
- GlaxoSmithKline
- Johnson Johnson
- Merck
- NIH-NIGMS [R01GM080269]
- Novartis
- NSF CCI Center for Selective C-H Functionalization [CHE-1205646]
- Pfizer
- Research Corporation
- Roche
- Yale University
- Baylor University
- Welch Foundation (Chair) [AA-006]
- Cancer Prevention & Research Institute of Texas (CPRIT) [R1309]
- Direct For Mathematical & Physical Scien
- Division Of Chemistry [1205646] Funding Source: National Science Foundation
Donor-acceptor cyclopropanes are convenient precursors to reactive and versatile 1,3-dipoles, and have found application in the synthesis of a variety of carbo- and heterocyclic scaffolds. This perspective review details our laboratory's use of donor-acceptor cyclopropanes as intermediates toward the total synthesis of various natural products. We also discuss our work in the development of novel cycloadditions and rearrangements of donor-acceptor cyclopropanes and aziridines, as well as an example of an aryne insertion proceeding via fragmentation of a transient donor-acceptor cyclobutane.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据